AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
16.20
-0.38 (-2.29%)
Mar 27, 2026, 4:00 PM EDT - Market closed
PSIL Holdings Information
PSIL is an equity ETF with a total of 30 individual holdings. The top holdings are AtaiBeckley stock at 10.06%, Relmada Therapeutics at 9.87%, Definium Therapeutics at 8.44%, COMPASS Pathways at 6.94%, and Alto Neuroscience at 5.21%.
Total Holdings
30
Top 10 Percentage
64.53%
Asset Class
Equity
ETF Category
Miscellaneous Sector
Assets
19.79M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ATAI | AtaiBeckley Inc. | 10.06% |
| 2 | RLMD | Relmada Therapeutics, Inc. | 9.87% |
| 3 | DFTX | Definium Therapeutics, Inc. | 8.44% |
| 4 | CMPS | COMPASS Pathways plc | 6.94% |
| 5 | ANRO | Alto Neuroscience, Inc. | 5.21% |
| 6 | NRXP | NRx Pharmaceuticals, Inc. | 5.07% |
| 7 | GHRS | GH Research PLC | 4.84% |
| 8 | NBIX | Neurocrine Biosciences, Inc. | 4.71% |
| 9 | ALKS | Alkermes plc | 4.70% |
| 10 | CSE: DRUG | Bright Minds Biosciences Inc. | 4.68% |
| 11 | NEO: HELP | Cybin Inc. | 4.65% |
| 12 | SUPN | Supernus Pharmaceuticals, Inc. | 4.37% |
| 13 | ABBV | AbbVie Inc. | 4.32% |
| 14 | JNJ | Johnson & Johnson | 4.30% |
| 15 | n/a | Blackrock Treasury Trust Instl 62 | 4.18% |
| 16 | STIM | Neuronetics, Inc. | 4.12% |
| 17 | NEUP | Neuphoria Therapeutics Inc. | 3.40% |
| 18 | CSE: QNTM | Quantum BioPharma Ltd. | 1.39% |
| 19 | KTTA | Pasithea Therapeutics Corp. | 1.32% |
| 20 | SILO | Silo Pharma, Inc. | 1.26% |
| 21 | VTGN | Vistagen Therapeutics, Inc. | 0.85% |
| 22 | TSX: NUMI | Numinus Wellness Inc. | 0.57% |
| 23 | IXHL | Incannex Healthcare Inc. | 0.40% |
| 24 | ENVB | Enveric Biosciences, Inc. | 0.17% |
| 25 | n/a | Cash | 0.15% |
As of Mar 25, 2026